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Summary
Objectives: The objective of this study was to link the Western Ontario and McMaster Universities (WOMAC) and Lequesne-Algofunctional
indices to the ICF on the basis of linking rules developed specifically to accomplish this aim. The linking process enables the understanding
of the relationship between health-status measures and the ICF.
Methods: Since the fifth World Health Organisation/International Liege Against Rheumatism (WHO/ILAR) Task Force and the Outcome
Measures in Rheumatology Clinical Trials (OMERACT) group recommend the use of WOMAC and the Lequesne-Algofunctional indices in
patients with osteoarthritis of the hip and knee in clinical trials, these two health-status measures have been used in this study.
Both health-status measures were linked to the ICF separately by two trained health professionals. Consensus between health professionals
was used to decide which ICF category should be linked to each item/concept of the two questionnaires. To resolve disagreements between
the two health professionals, a third person trained in the linking rules was consulted.
Results: Except for the concept of ‘morning stiffness’, both health professionals agreed on the ICF category chosen to link all the
items/concepts of both questionnaires. Altogether, 29 different ICF categories have been linked. Five ICF categories belong to the ICF
component ‘body functions’, 23 categories to the component ‘activities and participation’, and one category to ‘environmental factors’. Both
questionnaires have 10 ICF categories in common.
Conclusions: The results of the linking process reflect both the structure of the two questionnaires studied and the relationship between them,
showing that the ICF classification can become the cardinal reference for existing health-status measures.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Introduction
Research and clinical management of patients with osteo-
arthritis (OA) rely on the sound measurement of pain,
functional limitations, and stiffness. The Outcome Meas-
ures in Rheumatology Clinical Trials (OMERACT) group
recommended the obligatory use of the domains pain and
physical function in Phase-III clinical trials, and described
stiffness as an important optional domain1. Health-status
measures have been developed accordingly and applied in
clinical research and practice.
A number of international organisations, like the fifth
World Health Organisation/International Liege Against
Rheumatism (WHO/ILAR) Task Force and the OMERACT
group have examined the condition-specific health-status
measures, which are currently available with respect to
their properties, and have made suggestions regarding
their use2–4. The Western Ontario and McMaster
Universities (WOMAC) OA index4–6 and the Lequesne-
Algofunctional index7–10 may be the most recommended
and most frequently used outcome measures for OA of the
hip and knee in clinical trials.
The WOMAC is a three-dimensional, condition-specific
instrument with 24 questions that cover pain, stiffness, and
physical function. The WOMAC has been widely used in
recent clinical studies of drug therapy11, surgical treat-
ment12, and physiotherapy13.
The Lequesne-Algofunctional index comprises three sec-
tions with a total of 10 questions. The first section inquires
about the severity of pain, the second section evaluates
walking ability, and the third section relates to physical
function.
Both the WOMAC and the self-administered Lequesne-
Algofunctional indices are closely related disease-specific
measures of symptom severity and physical disability in
patients with OA of the lower extremities. Except for the
WOMAC Stiffness Scale in patients with OA of the hip,
which demonstrates weak intraobserver reliability, both
instruments and subscales have satisfactory intraobserver
reliability14.
None of the above-mentioned organisations has sug-
gested describing or classifying health using classifi-
cations, such as the ICIDH-115. The ICIDH-1 has not been
widely used in research or practice in most countries.
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One obvious reason was that the classification had only
been approved for field trials. However, in May 2001, the
successor of the ICIDH-1, the ICIDH-2 or International
Classification of Functioning, Disability, and Health, was
approved by the World Health Assembly16, and the acro-
nym was changed to ICF. Owing to the increasing impor-
tance of the ICF, ongoing developments have rendered the
ICF practical for clinical research and clinical practice17.
Therefore, the ICF will probably be increasingly used in
future clinical and epidemiological trials, as well as in health
reports.
In the future, health will probably be described with the
existing outcome measures, as well as with the ICF, in
clinical research, research on health services, and clinical
practice. Both approaches have their strength. Most impor-
tantly, the disease-specific outcome measures, such as the
WOMAC or Lequesne-Algofunctional index, are primarily
designed as process measures. They are, therefore, useful
to detect changes in the short term. In contrast to these
questionnaires, the ICF is a general health-status frame-
work. Indeed, the ICF can serve as a basis for the selection
of instruments based on their content validity.
It is, therefore, very important to understand the relation-
ship between outcome measures, such as the WOMAC
and Lequesne-Algofunctional indices, and the ICF. The
basis for this understanding is the linkage of individual
items of the WOMAC and the Lequesne-Algofunctional
indices to the ICF.
Accordingly, the objective of our study was to link the
WOMAC and Lequesne-Algofunctional indices to the ICF




The WOMAC index is a three-dimensional, self-
administered, disease-specific, health-status measure to
investigate patient-relevant and clinically important out-
comes of therapies of OA of the lower extremities. It
consists of 24 items: five items are related to pain, two
items to stiffness, and 17 items to physical function. Re-
sponses are given on 10-cm horizontal visual-analogue
scales. Aggregate scores for each dimension are deter-
mined by summing the component item scores for each
dimension19.
The Lequesne-Algofunctional index includes three sec-
tions with a total of 10 questions. It was developed using an
interview format, but an adapted version for questionnaire
use also exists14. The first section includes five items and
measures pain or discomfort under different situations. The
second section asks about the maximum walking distance.
If patients use one or two walking aids, the score is
increased by one and two points, respectively. The third
section addresses physical disability. This section differs for
patients with OA of the knee or hip. For each condition, the
third section contains four items. Responses are given on
Likert scales. The Lequesne-Algofunctional index is scored
as the sum of all items. The score range of each section is
from 0 to 8, resulting in a total score ranging from 0 to 24.
The International Classification of Functioning, Disability,
and Health, known as the ICF16, is a multipurpose classi-
fication belonging to the WHO family of international classi-
fications and is designed to record and organise a wide
range of information about health and health-related states.
The ICF has two parts, each containing two separate
components, described as follows:
Part 1: covers functioning and disability and includes the
following components:
1. Body functions (b) and structure (s) and
2. Activities and participation (d).
Part 2: covers contextual factors and includes the follow-
ing components:
1. Environmental factors (e) and
2. Personal factors.
In the ICF classification, the letters b, s, d, and e, which
refer to the component of the classification, are followed by
a numeric code starting with the chapter number (one digit)
followed by the second level (two digits), and the third
and fourth level (one digit each). For example, the body
functions classification contains the following codes:
b2: sensory functions and pain
b280: sensation of pain
b2801: pain in body part
b28015: pain in lower limb
LINKAGE OF ITEMS TO THE ICF
The WOMAC and the Lequesne-Algofunctional indices
were linked to the ICF separately by two trained health
professionals on the basis of 10 linking rules, which enable
health-status measures to be linked to the ICF in a specific
and precise manner18. The most important linking rules are
presented below:
• Each item of an outcome measure should be linked to
the most precise ICF category.
• If one item encompasses different constructs, the
information in each construct should be linked. For
example, in item 1B of the Lequesne-Algofunctional
index ‘morning stiffness or regressive pain after rising’,
the concepts ‘morning stiffness’ and ‘pain after rising’
have been linked to the ICF.
• The response options of an item are linked if they refer
to additional constructs.
• If the information provided by the item is not sufficient
for making a decision about the most appropriate ICF
category, then this item should be linked ‘nd’ (not
definable).
• If an item is not contained in the ICF classification, then
this item is assigned ‘nc’ (not covered by the ICF).
Consensus between health professionals was used to
decide which ICF category should be linked to each item/
concept of the two questionnaires. To resolve disagree-
ments between the two health professionals concerning the
selected categories, a third person trained in the linking
rules was consulted. In a discussion led by the third person,
the two health professionals who linked the item stated
their pros and cons for the linking of the concept under
question to a specific ICF category. Based on these state-
ments, the third person made an informed decision.
Results
Table I shows the results of the linking process of the
WOMAC and the Lequesne-Algofunctional indices. The
items/concepts of the questionnaires have been linked to
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Table I
Items of the WOMAC and the Lequesne-Algofunctional indices and the corresponding ICF domains/categories
WOMAC items ICF code Lequesne items
Body functions
3. Pain at night while in bed b134 Sleep functions
1.–5. Arthritis pain b28016 Pain in joints 1A–E: Pain or discomfort
1B: Morning stiffness or regressive pain after
rising
b289 Sensation of pain, other specified and
unspecified
1A–E: Pain or discomfort
b7603 Supportive functions of arm or leg 3D: Pain or discomfort while getting up from
sitting without the help of arms
6. Stiffness after first wakening in the
morning
b7800 Sensation of muscle stiffness or 1B: Morning stiffness or regressive pain after
rising
7. Stiffness after sitting, lying or resting
later in the day
b7808 Sensations related to muscles and
movement functions, other specified
Activities and participation
d4100 Lying down 1B: Morning stiffness or regressive pain after
rising
d4101 Squatting 3C (hip): Squat or bend on the knees
10. Rising from sitting d4103 Sitting 1E (knee): Pain or discomfort while getting up
from sitting without the help of arms
17. Rising from bed
12. Bending to floor d4105 Bending 3A (hip): Put on socks by bending forward
3C (Hip): Squat or bend on the knees
4. Pain sitting or lying d4150 Maintaining a lying position 1A: Pain or discomfort during nocturnal bed rest
7. Stiffness after sitting, lying or resting
later in the day
19. Lying in bed
4. Pain sitting or lying d4153 Maintaining a sitting position 1E (hip): Pain or discomfort with prolonged
sitting (2 h)
7. Stiffness after sitting, lying or resting
later in the day
21. Sitting
5. Pain standing upright d4154 Maintaining a standing position 1C: Pain or discomfort after standing for 30 min
11. Standing
d4400 Picking up 3B (hip): Pick up an object from the floor
d4102 Transferring oneself while lying 1A: Pain or discomfort during nocturnal bed rest
only on movement or in certain positions
1. Pain walking on a flat surface d450 Walking
13. Walking on flat surface
d4500 Walking short distances 2. Maximum distance walked (may walk with
pain)
1 km (in about 15 min)
from 500 to 900 m (in about 8–15 min)
from 300 to 500 m
from 100 to 300 m
less than 100 m
d4501 Walking long distances 2. Maximum distance walked (may walk with
pain)
Unlimited
d4502 Walking on different surfaces 3D (knee): Able to walk on uneven ground
2. Pain going up or down stairs d4551 Climbing 3A (knee): climb up a one flight of stairs
8. Descending stairs 3B (knee): Climb down one flight of stairs
9. Ascending stairs
d4559 Moving around unspecified 1D: Pain or discomfort while ambulating
14. Getting in/out of car d498 Mobility, other specified 3D (hip): Can get into and out of a car
20. Getting in/out of bath d5101 Washing whole body
22. Getting on/off toilet d530 Toileting
16. Putting on socks/stockings d5402 Putting on footwear 3A (hip): Put on socks by bending forward
18. Taking off socks/stockings d5403 Taking off footwear
15. Going shopping d6200 Shopping
23. Heavy domestic duties d699 Domestic life, unspecified
24. Light domestic duties
7. How severe is your stiffness after sitting,
lying or resting later in the day?
d9208 Recreation and leisure, other
specified
Environmental factors
e1201 Assistive products and technology
for personal indoor and outdoor mobility
2. Maximum distance walked (may walk with
pain){with one walking stick or crutch
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29 ICF categories. Disagreement between the first and
second health professional occurred in one concept. The
concept ‘morning stiffness’ was linked to the ICF category
‘sensation of muscle stiffness’ (b7800) by one health pro-
fessional and to the ICF category ‘sensations related to
muscles and movement functions, other specified’ (b7808)
by the other. On the basis of the third opinion, the latter ICF
category (b7808) was chosen.
Altogether, 29 different ICF categories have been linked.
Five ICF categories belong to the ICF component ‘body
functions’, 23 categories to the component ‘activities and
participation’, and one category to ‘environmental factors’.
Both questionnaires have 10 ICF categories in common.
Two of the 10 categories correspond to the component
body functions ‘pain in joints’ (b28016) and ‘sensation of
muscle stiffness’ (b7800), five belong to the ICF domain
‘changing and maintaining body position’ (d4103, d4105,
d4150, d4153, d4154), one to the ICF category ‘climbing’
(d4451), another to the ICF category ‘putting on footwear’
(d5402), and the last one to the ICF category ‘mobility,
other specified’ (d498).
The ICF categories that are not common to both ques-
tionnaires correspond to six different activities, like ‘getting
on/off toilet’ or ‘going shopping’ (see the following ICF
categories in Table I: d450, d5101, d530, d5403, d6200,
d699) that are contained in the WOMAC questionnaire and
not in the Lequesne-Algofunctional index. The category
d450 ‘walking’ is represented in both instruments. The
Lequesne Algofunctional index accents the distance (‘maxi-
mum distance walked{’), whereas the WOMAC accents the
kind of surface (‘walking on flat surface’). Therefore, both
instruments are linked to different ICF categories within
the domain ‘walking’ (d450). Additionally, the Lequesne-
Algofunctional index contains the activities ‘lying down’,
‘squatting’, ‘picking up’, ‘transferring oneself while
lying’, and ‘moving around unspecified’, which are not
represented in the WOMAC.
Discussion
Linking of all the items of most widely used, self-
administered, condition-specific instruments for patients
with OA to the ICF has been possible on the basis of widely
tested linking rules.
Most of the items on both instruments could be linked on
one-to-one basis to the categories of the ICF classification.
Nevertheless, in a few cases, the ICF category did not
cover all the information contained in the item or concepts
in the questionnaires. For example, the item ‘getting in and
out of a car’ could not be exactly linked to the ICF. Thus,
this item was linked to the parent category ‘mobility, other
specified’ (d498). The additional information contained in
the item should be documented separately, making the
linking exercise a more complicated process.
The important clinical symptom ‘morning stiffness’, which
is one of the disease-defining ACR criteria for OA20, is not
explicitly named in the ICF. In this exercise, it has been
linked to ‘sensations of muscles and movement functions,
other specified’ (b7808). However, there are valid argu-
ments for the linkage of morning stiffness to b7800, muscle
stiffness. The reason, why ‘b7808’ was preferred, was that
the muscle stiffness does not necessarily represent what is
being meant by morning stiffness in patients with OA, since
morning stiffness in OA also encompasses stiffness related
to structures other than muscles. Therefore, it was felt that
the broader definition of b7808 is more appropriate. Since
there is no more precise definition of stiffness in the ICF in
its current edition, it is not possible to make a final decision
about the most appropriate linkage at this point. Therefore,
both the linkage to b7800, muscle stiffness, as well as
b7808, sensations related to muscle and movement
functions, other specified, may be considered valid.
Accordingly, both ICF codes are shown in Table I.
On the basis of this exercise, it has also been shown that
the ICF is very precise in describing activities of patients.
For example, the WOMAC items ‘putting on socks’ and
‘taking off socks’ could be linked to the corresponding ICF
codes ‘putting on footwear’ (d5202) and ‘taking off foot-
wear’ (d5403) without losing essential information. The item
‘pick up an object from the floor’ could be linked very
precisely to the ICF category ‘picking up’ (d4400). The ICF
categories describing the activity ‘walking’ represent a
further example that the ICF classification can be very
precise and useful in describing impairments in patients’
activities.
Although outcome-measurement instruments, like the
WOMAC and the Lequesne-Algofunctional indices, can be
linked to the ICF, the ICF is no substitute for these instru-
ments. As has been shown in the example of the clinical
symptom ‘morning stiffness’, it makes sense to use the ICF
and health-status measure together in clinical studies. The
ICF can be very helpful in adding additional information to
the already existing instruments, and objectively describing
the impairments in activities and body functions of study
populations. It, thereby, improves the comparability of clini-
cal trials. The simultaneous application of the ICF and
health-status measures demonstrates the usefulness of the
ICF in creating a common language for clinical practice,
teaching, and research.
As has been shown in this exercise, the results of the
linking process reflect both the structure of the two ques-
tionnaires studied and the relationship between them,
showing that the ICF classification can become the cardinal
reference for existing health-status measures.
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